z-logo
open-access-imgOpen Access
Pneumolysin-Induced Complement Depletion during Experimental Pneumococcal Bacteremia
Author(s) -
Rosemarie B. Alcantara,
Laurel C. Preheim,
Martha J. Gentry-Nielsen
Publication year - 2001
Publication title -
infection and immunity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.508
H-Index - 220
eISSN - 1070-6313
pISSN - 0019-9567
DOI - 10.1128/iai.69.6.3569-3575.2001
Subject(s) - pneumolysin , streptococcus pneumoniae , microbiology and biotechnology , opsonin , biology , bacteremia , pneumococcal infections , streptococcaceae , complement system , immunology , phagocytosis , alternative complement pathway , antibody opsonization , antibody , antibiotics
To quantify complement depletion by pneumolysin during Streptococcus pneumoniae bacteremia, cirrhotic and control rats were infected intravenously with one of three isogenic mutant strains of S. pneumoniae expressing different forms of pneumolysin. Outcome measures included clearance of the organisms from the bloodstream, alterations in 50% serum hemolytic complement (CH(50)) activity and complement C3 levels during infection, and serum opsonic capacity at 18 h postinfection. Cirrhotic rats had significantly lower CH(50) and C3 levels than control rats, both before and after infection. However, initial complement levels did not predict bacterial load after 18 h of infection. Changes in CH(50) and C3 levels over the 18-h period correlated with numbers of H+C+ but not H+C- or PLY- organisms in the bloodstream at 18 h postinfection. The sera of cirrhotic rats infected with the H+C+ strain had significantly decreased levels of C3 and showed significantly lower opsonizing activity for S. pneumoniae than sera from H+C+-infected control rats. These studies suggest that under limiting concentrations of complement, the expression of pneumolysin by pneumococci has a significant, negative effect on serum complement levels and reduces serum opsonic activity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here